Patents

Inhibitex Reports First Quarter 2007 Financial Results

Published in Lab Business Week, June 3rd, 2007

Inhibitex, Inc. (Nasdaq: INHX) today announced its financial results for the three months ended March 31, 2007. The Company reported that it held $59.6 million in cash, cash equivalents and short-term investments as of March 31, 2007, as compared to $61.4 million at December 31, 2006.

"The first quarter of 2007 was a highly productive and dynamic period for us on many fronts," stated Russell H. Plumb, president and chief executive officer of Inhibitex. "With the benefit of several significant one-time items and a continued emphasis on appropriately managing our cost structure, we were able to report positive operating results. In addition, we further leveraged our...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2007-06-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry